Comment on High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa

Authors
Publication date
27 November 2020
Publisher
Henry Ford Health Scholarly Commons

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Henry Ford Health System Scholarly Commons

    redirect
    oaioai:scholarlycommons.henryford...
    Last time updated on 17/03/2021